Back
Innodata, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Buy
57
INOD
Innodata, Inc.
Last Price:
$52.50
Seasonality Move:
7.59%
Sell
45
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$400.36
Seasonality Move:
0.84%
Buy
57
Innodata, Inc. (INOD)
is a Buy
Is Innodata, Inc. a Buy, Sell or Hold?
-
The current Innodata, Inc. [INOD] share price is $52.51. The Score for INOD is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
INOD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $400.59. The Score for ALNY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INOD Stock Price Chart
What is Innodata, Inc.'s stock price today?
-
The Innodata, Inc. share price today is $52.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INOD is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $400.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
INOD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.36 | Sell |
| Relative Strength Index (14 RSI): | 43.25 | Sell |
| Chaikin Money Flow: | -76354 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.13 - 57.57) | Sell |
| Bollinger Bands (100): | (45.25 - 75.35) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.45 | Sell |
| Relative Strength Index (14 RSI): | 38.95 | Sell |
| Chaikin Money Flow: | -39207 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (397.3 - 450.5) | Sell |
| Bollinger Bands (100): | (425.24 - 469.88) | Sell |
INOD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.71 | Buy |
| 20-day SMA: | 54.25 | Sell |
| 50-day SMA: | 61.64 | Sell |
| 200-day SMA: | 51.25 | Buy |
| 8-day EMA: | 52.67 | Sell |
| 20-day EMA: | 54.21 | Sell |
| 50-day EMA: | 58.45 | Sell |
| 200-day EMA: | 52.74 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 398.41 | Buy |
| 20-day SMA: | 420.3 | Sell |
| 50-day SMA: | 441.36 | Sell |
| 200-day SMA: | 368.84 | Buy |
| 8-day EMA: | 402.05 | Sell |
| 20-day EMA: | 414.25 | Sell |
| 50-day EMA: | 429.84 | Sell |
| 200-day EMA: | 383.48 | Buy |
Innodata, Inc. Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.26 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.20 per share, and an increase next year of $6.23 per share.
Innodata, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||